STOREBRAND ASSET MANAGEMENT AS
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1685676
LYSAKER, Q8
Position in ALNY
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$21,372,547
-$8,363,720 QoQ
Shares Held
64,595
-13.6% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STOREBRAND ASSET MANAGEMENT AS holds $182,532,224 across 11 Biotechnology names. ALNY ranks #4 (11.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
102,567 | $45,800,268 | |
| 2 | RPRX |
Royalty Pharma plc
|
776,642 | $37,255,516 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
35,939 | $27,767,908 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
64,595 | $21,372,547 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
109,134 | $20,631,782 | |
| 6 | INSM |
INSMED Inc
|
90,826 | $14,851,867 | |
| 7 | INCY |
Incyte Corp
|
80,755 | $7,600,660 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
53,365 | $5,189,746 |
All Filings in ALNY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $21,372,547 | 64,595 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $29,736,267 | 74,780 | Shares | Sole | 2026-05-20 | |
| 2025-09-30 | $32,839,752 | 72,017 | Shares | Sole | 2026-06-03 | |
| 2025-06-30 | $14,452,634 | 44,321 | Shares | Sole | 2026-06-03 | |
| 2025-03-31 | $12,163,590 | 45,047 | Shares | Sole | 2026-06-03 | |
| 2024-12-31 | $10,652,483 | 45,270 | Shares | Sole | 2026-06-17 | |
| 2024-09-30 | $6,376,020 | 23,183 | Shares | Sole | 2026-06-17 | |
| 2024-06-30 | $2,742,498 | 11,286 | Shares | Sole | 2026-06-17 | |
| 2024-03-31 | $2,765,721 | 18,506 | Shares | Sole | 2026-06-17 | |
| 2023-12-31 | $6,861,091 | 35,845 | Shares | Sole | 2026-06-18 | |
| 2023-09-30 | $6,003,867 | 33,901 | Shares | Sole | 2026-06-18 | |
| 2023-06-30 | $7,718,401 | 40,636 | Shares | Sole | 2026-06-18 | |
| 2023-03-31 | $8,335,916 | 41,613 | Shares | Sole | 2026-06-18 | |
| 2022-12-31 | $10,088,717 | 42,452 | Shares | Sole | 2026-06-18 | |
| 2022-09-30 | $8,246,391 | 41,199 | Shares | Sole | 2026-06-18 | |
| 2022-06-30 | $6,642,009 | 45,540 | Shares | Sole | 2026-06-18 | |
| 2022-03-31 | $7,488,316 | 45,859 | Shares | Sole | 2026-06-18 | |
| 2021-12-31 | $8,963,150 | 52,855 | Shares | Sole | 2026-06-18 | |
| 2021-09-30 | $10,064,894 | 53,307 | Shares | Sole | 2026-06-18 | |
| 2021-06-30 | $9,315,463 | 54,952 | Shares | Sole | 2026-06-18 | |
| 2021-03-31 | $7,758,672 | 54,952 | Shares | Sole | 2026-06-18 | |
| 2020-12-31 | $6,448,721 | 49,617 | Shares | Sole | 2026-06-18 | |
| 2020-09-30 | $5,456,651 | 37,477 | Shares | Sole | 2026-06-18 | |
| 2020-06-30 | $5,386,168 | 36,366 | Shares | Sole | 2026-06-18 | |
| 2020-03-31 | $2,985,755 | 27,430 | Shares | Sole | 2026-06-18 | |
| No filing history on record for this holder in this stock. | ||||||